| Ms Bonnie Leigh Schlegelmann, PT | |
|
400 Hickory St Nw Ste 201, Albany, OR 97321-1700 | |
| (541) 812-5840 | |
| Not Available |
| Full Name | Ms Bonnie Leigh Schlegelmann |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 38 Years |
| Location | 400 Hickory St Nw Ste 201, Albany, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770528812 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 3225 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Albany General Hospital | 9931097987 | 162 |
News Archive
People with drug problems don't often come to mind as an underserved population regarding health care. Yet, because of their substance abuse issues, they often go without essential medical services, particularly when it comes to caring for their teeth and other oral tissues.
Even a partial report from the Congressional Budget Office was enough to apparently tip the scales against the latest Republican effort to overhaul the Affordable Care Act and prompted a crucial senator to announce she cannot support the bill, seemingly sinking its chances.
Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of CUVPOSA™ (glycopyrrolate), the first liquid treatment for patients ages 3-16 who suffer from chronic severe drooling associated with neurologic conditions such as cerebral palsy. CUVPOSA™ was designated an Orphan Drug by the FDA.
Athletes have long known about the natural "high" exercise can induce. Now, for the first time, medical researchers have demonstrated that exercise can reverse the effects in the brain of psychological trauma experienced early in life.
› Verified 5 days ago
| Entity Name | Albany General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154372340 PECOS PAC ID: 9931097987 Enrollment ID: O20040310000310 |
News Archive
People with drug problems don't often come to mind as an underserved population regarding health care. Yet, because of their substance abuse issues, they often go without essential medical services, particularly when it comes to caring for their teeth and other oral tissues.
Even a partial report from the Congressional Budget Office was enough to apparently tip the scales against the latest Republican effort to overhaul the Affordable Care Act and prompted a crucial senator to announce she cannot support the bill, seemingly sinking its chances.
Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of CUVPOSA™ (glycopyrrolate), the first liquid treatment for patients ages 3-16 who suffer from chronic severe drooling associated with neurologic conditions such as cerebral palsy. CUVPOSA™ was designated an Orphan Drug by the FDA.
Athletes have long known about the natural "high" exercise can induce. Now, for the first time, medical researchers have demonstrated that exercise can reverse the effects in the brain of psychological trauma experienced early in life.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Bonnie Leigh Schlegelmann, PT Po Box 1188, Corvallis, OR 97339-1188 Ph: () - | Ms Bonnie Leigh Schlegelmann, PT 400 Hickory St Nw Ste 201, Albany, OR 97321-1700 Ph: (541) 812-5840 |
News Archive
People with drug problems don't often come to mind as an underserved population regarding health care. Yet, because of their substance abuse issues, they often go without essential medical services, particularly when it comes to caring for their teeth and other oral tissues.
Even a partial report from the Congressional Budget Office was enough to apparently tip the scales against the latest Republican effort to overhaul the Affordable Care Act and prompted a crucial senator to announce she cannot support the bill, seemingly sinking its chances.
Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of CUVPOSA™ (glycopyrrolate), the first liquid treatment for patients ages 3-16 who suffer from chronic severe drooling associated with neurologic conditions such as cerebral palsy. CUVPOSA™ was designated an Orphan Drug by the FDA.
Athletes have long known about the natural "high" exercise can induce. Now, for the first time, medical researchers have demonstrated that exercise can reverse the effects in the brain of psychological trauma experienced early in life.
› Verified 5 days ago
Blake Alexander Evans, Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 400 Hickory St Nw, Albany, OR 97321 Phone: 541-812-5840 |